Biomea Fusion, Inc. (BMEA)

NASDAQ: BMEA · Real-Time Price · USD

2.295

+0.235 (11.41%)

At close: Apr 24, 2025, 4:00 PM

2.310

+0.015 (0.65%)

After-hours: Apr 24, 2025, 7:08 PM EDT

Biomea Fusion Employees

Biomea Fusion had 106 employees as of December 31, 2024. The number of employees increased by 3 or 2.91% compared to the previous year.

Employees

106

Change (1Y)

3

Growth (1Y)

2.91%

Revenue / Employee

n/a

Profits / Employee

-$1,305,906

Market Cap

86.23M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	106	3	2.91%
Dec 31, 2023	103	20	24.10%
Dec 31, 2022	83	32	62.75%
Dec 31, 2021	51	39	325.00%
Dec 31, 2020	12	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novartis AG	75,883

Employee Rankings

BMEA News

23 days ago - Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
24 days ago - Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewsWire
4 weeks ago - Biomea Fusion Announces Leadership Transition - GlobeNewsWire
4 weeks ago - Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose - GlobeNewsWire
7 weeks ago - Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
2 months ago - Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes - GlobeNewsWire
4 months ago - Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday? - Benzinga
4 months ago - Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes - GlobeNewsWire